Sailong Pharmaceutical Group Co.,Ltd. (SHE:002898)
China flag China · Delayed Price · Currency is CNY
13.76
-0.19 (-1.36%)
Sep 12, 2025, 2:45 PM CST

SHE:002898 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2016 - 2020
2,4201,6932,4592,1381,8391,647
Upgrade
Market Cap Growth
29.27%-31.14%14.98%16.27%11.64%-25.82%
Upgrade
Enterprise Value
2,5691,7762,5292,2151,9151,706
Upgrade
Last Close Price
13.759.6213.9412.1210.439.34
Upgrade
PE Ratio
--257.90---
Upgrade
Forward PE
-53.8953.8953.8953.8953.89
Upgrade
PS Ratio
9.956.427.928.097.4413.65
Upgrade
PB Ratio
4.993.394.594.063.262.81
Upgrade
P/TBV Ratio
5.823.925.244.663.733.22
Upgrade
P/FCF Ratio
--479.45-461.13-
Upgrade
P/OCF Ratio
--68.86151.4051.879430.41
Upgrade
EV/Sales Ratio
10.566.748.148.387.7514.14
Upgrade
EV/EBITDA Ratio
-194.1154.64-342.75-
Upgrade
EV/EBIT Ratio
--188.96---
Upgrade
EV/FCF Ratio
-78.08-493.11-480.25-
Upgrade
Debt / Equity Ratio
0.320.330.240.270.310.21
Upgrade
Debt / EBITDA Ratio
-14.712.74-25.42-
Upgrade
Debt / FCF Ratio
--24.85-43.39-
Upgrade
Asset Turnover
0.310.330.370.310.290.15
Upgrade
Inventory Turnover
2.201.932.242.191.500.80
Upgrade
Quick Ratio
0.490.600.700.610.870.78
Upgrade
Current Ratio
0.870.981.130.861.091.28
Upgrade
Return on Equity (ROE)
-9.76%-6.40%1.80%-6.85%-4.06%-10.79%
Upgrade
Return on Assets (ROA)
-2.94%-1.75%1.01%-3.06%-1.92%-5.81%
Upgrade
Return on Capital (ROIC)
-3.49%-2.14%1.26%-3.77%-2.25%-6.63%
Upgrade
Return on Capital Employed (ROCE)
--2.30%---
Upgrade
Earnings Yield
-2.06%-1.96%0.39%-1.75%-1.27%-4.08%
Upgrade
FCF Yield
-1.36%-4.34%0.21%-0.46%0.22%-3.88%
Upgrade
Dividend Yield
--0.14%---
Upgrade
Payout Ratio
--58.52%---
Upgrade
Buyback Yield / Dilution
0.28%-0.07%0.06%0.01%-0.01%-0.04%
Upgrade
Total Shareholder Return
--0.07%0.20%0.01%-0.01%-0.04%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.